Corcept Therapeutics
Company Description
Corcept Therapeutics wants to help people who are beyond blue. The biotechnology firm is exploring treatments that regulate the presence of cortisol, a steroid hormone associated with some psychiatric and metabolic disorders. Its sole commercial product, Korlym, is a version of the compound mifepristone (commonly known as RU-486 or the "abortion pill") used to regulate release patterns of cortisol. The drug is approved in the US for use in patients with Cushing''s Syndrome, a metabolic disorder
Product Categories (5)
149 Commonwealth Drive
Menlo Park, CA 94025
United States